An association study of a neurotrophin-3 (NT-3) gene polymorphism with schizophrenia

被引:28
|
作者
Dawson, E
Powell, JF
Sham, PC
Nothen, M
Crocq, MA
Propping, P
Korner, J
Rietschel, M
vanOs, J
Wright, P
Murray, RM
Gill, M
机构
[1] INST PSYCHIAT,DEPT PSYCHOL MED,GENET SECT,LONDON SE5 8AF,ENGLAND
[2] UNIV BONN,INST HUMAN GENET,W-5300 BONN,GERMANY
[3] CTR HOSP SPECIALISE,ROUFFACH,FRANCE
[4] UNIV BONN,DEPT PSYCHIAT,W-5300 BONN,GERMANY
[5] ST JAMES HOSP,TRINITY CTR HLTH SCI,DEPT PSYCHIAT,DUBLIN 8,IRELAND
关键词
association study; chromosome; 12; schizophrenia; neurodevelopment;
D O I
10.1111/j.1600-0447.1995.tb09607.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Since abnormalities of brain development play a role in the aetiology of schizophrenia, growth factors, known to play a role in neurodevelopment, such as neurotrophin-3 (NT-3), are therefore candidate genes for this disorder. The A3/147 bp allele of a dinucleotide repeat polymorphism in the promoter region of the NT-3 gene has been reported as occurring more frequently in a sample of Japanese schizophrenics compared to controls. We have determined the frequency of alleles of this polymorphism in 175 Caucasian schizophrenic patients and 147 control subjects. The patient and control samples showed no significant deviation from Hardy-Weinberg equilibrium and, in a test of all alleles, the patients and controls did not differ significantly in allele frequencies. However, the male schizophrenics were more likely than male controls to have the A3/147 bp allele (P = 0.029).
引用
收藏
页码:425 / 428
页数:4
相关论文
共 50 条
  • [1] NEUROTROPHIN-3 GENE POLYMORPHISM ASSOCIATED WITH SCHIZOPHRENIA
    NANKO, S
    HATTORI, M
    KUWATA, S
    SASAKI, T
    FUKUDA, R
    DAI, XY
    YAMAGUCHI, K
    SHIBATA, Y
    KAZAMATSURI, H
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 (06) : 390 - 392
  • [2] Association studies of the DRD3 dopamine receptor gene and the NT-3 (neurotrophin-3) gene in unrelated schizophrenics
    Gaitonde, EJ
    Morris, AG
    Sivagnanasundaram, S
    McKenna, PJ
    Hunt, DM
    Mollon, JD
    [J]. SCHIZOPHRENIA RESEARCH, 1996, 18 (2-3) : IXA1 - IXA1
  • [3] In schizophrenia serum level of neurotrophin-3 (NT-3) is increased only if depressive symptoms are present
    Arabska, Jasmina
    Lucka, Anna
    Strzelecki, Dominik
    Wysokinski, Adam
    [J]. NEUROSCIENCE LETTERS, 2018, 684 : 152 - 155
  • [4] NEUROTROPHIN-3 GENE AND SCHIZOPHRENIA
    NANKO, S
    HATTORI, M
    KAZAMATSURI, H
    [J]. SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 44 - 45
  • [5] Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?
    de Miranda, A. S.
    de Barros, J. L. V. M.
    Teixeira, Antonio Lucio
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (12) : 1225 - 1238
  • [6] Lack of association of schizophrenia with the neurotrophin-3 gene locus
    Nimgaonkar, VL
    Zhang, XR
    Brar, JS
    DeLeo, M
    Ganguli, R
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1995, 92 (06) : 464 - 466
  • [7] DINUCLEOTIDE REPEAT POLYMORPHISM IN THE PROMOTER REGION OF NEUROTROPHIN-3 GENE (NT3)
    HATTORI, M
    KUWATA, S
    FUKUDA, R
    SASAKI, T
    SHIBATA, Y
    KAZAMATSURI, H
    NANKO, S
    [J]. HUMAN MOLECULAR GENETICS, 1993, 2 (09) : 1511 - 1511
  • [8] Neurotrophin-3 gene polymorphisms and schizophrenia: No evidence for linkage or association
    Gill, M
    Hawi, Z
    ONeill, FA
    Walsh, D
    Straub, RE
    Kendler, KS
    [J]. PSYCHIATRIC GENETICS, 1996, 6 (04) : 183 - 186
  • [9] ASSOCIATION OF NEUROTROPHIN-3 GENE VARIANT WITH SEVERE FORMS OF SCHIZOPHRENIA
    HATTORI, M
    NANKO, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 209 (02) : 513 - 518
  • [10] Expression of neurotrophin-3 (NT-3) and anterograde axonal transport of endogenous NT-3 by retinal ganglion cells in chick embryos
    von Bartheld, CS
    Butowt, R
    [J]. JOURNAL OF NEUROSCIENCE, 2000, 20 (02): : 736 - 748